◄ back to all posts

JNJ: Johnson & Johnson Stock

Written by | Jul 6, 2018

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 390,358.96
Enterprise Value ($M) 403,100.73
Book Value ($M) 58,955.00
Book Value / Share 22.40
Price / Book 6.62
NCAV ($M) -49,085.00
NCAV / Share -18.65
Price / NCAV -7.95

Profitability (mra)
Return on Invested Capital (ROIC) 0.17
Return on Assets (ROA) 0.10
Return on Equity (ROE) 0.25

Liquidity (mrq)
Quick Ratio 1.13
Current Ratio 1.44

Balance Sheet (mrq) ($M)
Current Assets 41,987.00
Assets 150,027.00
Liabilities 91,072.00
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income n/a
Net Income 15,297.00
Earnings Per Share Diluted 5.61
Earnings Per Share Basic 5.70

Cash Flow Statement (mra) ($M)
Cash From Operations 22,201.00
Cash from Investing -3,167.00
Cash from Financing -3,167.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
2019-02-13 13G State Street Corp 5.70 -2.82
2019-02-11 13G/A BlackRock Inc. 6.90 9.69
2019-02-11 13G/A Vanguard Group Inc 8.25 8.24

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2019-10-28 10-Q JNJ / Johnson & Johnson 10-Q – Quarterly Report – 10-Q
2019-07-29 10-Q JNJ / Johnson & Johnson 10-Q – Quarterly Report – 10-Q
2019-05-01 10-Q JNJ / Johnson & Johnson 10-Q Quarterly Report 1Q 10-Q 2019
2019-02-20 10-K JNJ / Johnson & Johnson 10-K 2018 (Annual Report)

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2020-01-24 435,744 9,051,900 4.81
2020-01-23 787,011 8,671,900 9.08
2020-01-22 984,735 10,305,300 9.56
2020-01-21 596,908 9,543,900 6.25

(click for more detail)

Similar Companies
CTLT – Catalent Inc. EBS – Emergent Biosolutions, Inc.
HSP – Hospira LCI – Lannett Co., Inc.
LLY – Eli Lilly & Co.


Financial data and stock pages provided by
Fintel.io




2018/07/06
◄ back to all posts
Holistic